The outbreak of the corona pandemic will be remembered for many years to come as a turning point, with a significant impact on how we plan, conduct and manage clinical trials.
- What did the corona pandemic teach us?
- What could we have done differently?
- What needs to be done now to be prepared for the future, especially with unexpected situations?
In the article, we will review the regulatory updates, the changes the field has experienced in recent years and the new trends that are leading the clinical research industry to a new way of thinking in the planning, design, execution and management of clinical trials.
